Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
36.78
+0.18 (0.49%)
Jan 17, 2025, 4:00 PM EST - Market closed
Bright Minds Biosciences Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Selling, General & Admin | 1.44 | 1.44 | 2.2 | 2.55 | 2.31 | 0.12 | |
| Research & Development | 1.18 | 1.18 | 5 | 12.18 | 6.31 | 0.35 | |
| Operating Expenses | 2.62 | 2.62 | 7.2 | 14.73 | 8.62 | 0.47 | |
| Operating Income | -2.62 | -2.62 | -7.2 | -14.73 | -8.62 | -0.47 | |
| Interest Expense | -0.01 | -0.01 | - | - | - | - | |
| Interest & Investment Income | 0.03 | 0.03 | - | - | - | - | |
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | 0.01 | 0.01 | 0.15 | - | |
| Other Non Operating Income (Expenses) | -0.2 | -0.2 | -0.19 | -0.24 | -0.18 | -0.01 | |
| EBT Excluding Unusual Items | -2.8 | -2.8 | -7.37 | -14.96 | -8.65 | -0.48 | |
| Asset Writedown | - | - | - | -0 | - | - | |
| Pretax Income | -2.8 | -2.8 | -7.37 | -14.96 | -8.65 | -0.48 | |
| Net Income | -2.8 | -2.8 | -7.37 | -14.96 | -8.65 | -0.48 | |
| Net Income to Common | -2.8 | -2.8 | -7.37 | -14.96 | -8.65 | -0.48 | |
| Shares Outstanding (Basic) | 4 | 4 | 4 | 2 | 2 | 1 | |
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 2 | 2 | 1 | |
| Shares Change (YoY) | 15.87% | 15.87% | 50.57% | 37.64% | 148.42% | 74.24% | |
| EPS (Basic) | -0.65 | -0.65 | -1.98 | -6.06 | -4.82 | -0.66 | |
| EPS (Diluted) | -0.65 | -0.65 | -1.98 | -6.06 | -4.82 | -0.66 | |
| Free Cash Flow | -1.85 | -1.85 | -7.02 | -13.59 | -7.32 | -0.29 | |
| Free Cash Flow Per Share | -0.43 | -0.43 | -1.89 | -5.50 | -4.08 | -0.40 | |
| EBIT | -2.62 | -2.62 | -7.2 | -14.73 | -8.62 | -0.47 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.